BioNexus Gene Lab (BGLC) Leases (2019 - 2025)
Historic Leases for BioNexus Gene Lab (BGLC) over the last 7 years, with Q3 2025 value amounting to $186082.0.
- BioNexus Gene Lab's Leases fell 2004.97% to $186082.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $186082.0, marking a year-over-year decrease of 2004.97%. This contributed to the annual value of $215243.0 for FY2024, which is 5206.79% up from last year.
- Latest data reveals that BioNexus Gene Lab reported Leases of $186082.0 as of Q3 2025, which was down 2004.97% from $200284.0 recorded in Q2 2025.
- In the past 5 years, BioNexus Gene Lab's Leases registered a high of $241700.0 during Q2 2024, and its lowest value of $24975.0 during Q3 2022.
- Its 5-year average for Leases is $111992.8, with a median of $55747.0 in 2021.
- Per our database at Business Quant, BioNexus Gene Lab's Leases tumbled by 4402.11% in 2022 and then soared by 46674.27% in 2023.
- BioNexus Gene Lab's Leases (Quarter) stood at $41090.0 in 2021, then skyrocketed by 35.63% to $55730.0 in 2022, then skyrocketed by 153.98% to $141544.0 in 2023, then soared by 52.07% to $215243.0 in 2024, then decreased by 13.55% to $186082.0 in 2025.
- Its last three reported values are $186082.0 in Q3 2025, $200284.0 for Q2 2025, and $203923.0 during Q1 2025.